Cargando…

Sex‐specific biomarkers in Alzheimer's disease progression: Framingham Heart Study

BACKGROUND: Sex differences in Alzheimer's disease (AD) are not well understood. METHODS: We performed sex‐specific analyses of AD and annualized cognitive decline with clinical and blood biomarker data in participants 60+ years old in the community‐based longitudinal Framingham Heart Study Off...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Chunyu, Li, Yi, Nwosu, Adaora, Ang, Ting Fang Alvin, Liu, Yulin, Devine, Sherral, Au, Rhoda, Doraiswamy, P. Murali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Diagnostic and Prognostic Assessment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633867/ https://www.ncbi.nlm.nih.gov/pubmed/36348973 http://dx.doi.org/10.1002/dad2.12369

Ejemplares similares

Life satisfaction across the entire trajectory of Alzheimer's disease: A mediation analysis
por: Mank, Arenda, et al.
Publicado: (2022)

Stronger implicit interference in cognitively healthy older participants with higher risk of Alzheimer's disease
por: Hung, Shao‐Min, et al.
Publicado: (2022)

Memory‐driven eye movements prospectively predict dementia in people at risk of Alzheimer's disease
por: Parra, Mario A, et al.
Publicado: (2022)

A proposed theoretical framework for retinal biomarkers
por: MacCormick, Ian James Callum, et al.
Publicado: (2022)

Evaluation of blood‐based, extracellular vesicles as biomarkers for aging‐related TDP‐43 pathology
por: Winston, Charisse N., et al.
Publicado: (2022)

Mayo normative studies: A conditional normative model for longitudinal change on the Auditory Verbal Learning Test and preliminary validation in preclinical Alzheimer's disease
por: Alden, Eva C., et al.
Publicado: (2022)

Is there a common latent cognitive construct for dementia estimation across two Chinese cohorts?
por: Liu, Yuyang, et al.
Publicado: (2022)

Establishing cognitive baseline in three generations: Framingham Heart Study
por: Yang, Jin, et al.
Publicado: (2023)

Exploring discordant low amyloid beta and high neocortical tau positron emission tomography cases
por: Krishnadas, Natasha, et al.
Publicado: (2022)

Comorbidity patterns in institutionalized older adults affected by dementia
por: Zazzara, Maria Beatrice, et al.
Publicado: (2022)

Weight loss in a cardiovascular trial population identifies people at future risk of dementia
por: van der Veere, Pieter, et al.
Publicado: (2022)

Development and design of a diagnostic report to support communication in dementia: Co‐creation with patients and care partners
por: van Gils, Aniek M., et al.
Publicado: (2022)

Medicare's Annual Wellness Visit and diagnoses of dementias and cognitive impairment
por: Thunell, Johanna A., et al.
Publicado: (2022)

Development and implementation of an electronic Clinical Dementia Rating and Financial Capacity Instrument‐Short Form
por: Howell, Taylor, et al.
Publicado: (2022)

No difference in retinal fluorescence after oral curcumin intake in amyloid‐proven AD cases compared to controls
por: den Haan, Jurre, et al.
Publicado: (2022)

Optimizing cCOG, a Web‐based tool, to detect dementia with Lewy Bodies
por: van Gils, Aniek M., et al.
Publicado: (2022)

Exploring the Hierarchical Influence of Cognitive Functions for Alzheimer Disease: The Framingham Heart Study
por: Ding, Huitong, et al.
Publicado: (2020)

Is dietary choline intake related to dementia and Alzheimer's disease risks? Results from the Framingham Heart Study
por: Yuan, Jing, et al.
Publicado: (2022)

Association Between the Digital Clock Drawing Test and Neuropsychological Test Performance: Large Community-Based Prospective Cohort (Framingham Heart Study)
por: Yuan, Jing, et al.
Publicado: (2021)

The DecisionDx-UM Gene Expression Profile Test Provides Risk Stratification and Individualized Patient Care in Uveal Melanoma
por: Harbour, J. William, et al.
Publicado: (2013)

Revolutionizing Alzheimer's disease and clinical trials through biomarkers
por: Mattsson, Niklas, et al.
Publicado: (2015)

Detection of presymptomatic Alzheimer's disease through breath biomarkers
por: Emam, Shadi, et al.
Publicado: (2020)

Challenges associated with biomarker-based classification systems for Alzheimer's disease
por: Illán-Gala, Ignacio, et al.
Publicado: (2018)

Development and validation of a salivary tau biomarker in Alzheimer's disease
por: Pekeles, Heather, et al.
Publicado: (2018)

Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and design
por: de Wilde, Arno, et al.
Publicado: (2017)

Multimodal prediction of conversion to Alzheimer's disease based on incomplete biomarkers
por: Ritter, Kerstin, et al.
Publicado: (2015)

Fusion of deep learning models of MRI scans, Mini–Mental State Examination, and logical memory test enhances diagnosis of mild cognitive impairment
por: Qiu, Shangran, et al.
Publicado: (2018)

Relationship between frailty and Alzheimer's disease biomarkers: A scoping review
por: Wallace, Lindsay, et al.
Publicado: (2018)

Clinical and biomarker trajectories in sporadic Alzheimer's disease: A longitudinal study
por: Wang, Hui‐Fu, et al.
Publicado: (2020)

Prognostic value of ATN Alzheimer biomarkers: 60‐month follow‐up results from the Argentine Alzheimer's Disease Neuroimaging Initiative
por: Allegri, Ricardo F., et al.
Publicado: (2020)

Characterizing heterogeneity in the progression of Alzheimer's disease using longitudinal clinical and neuroimaging biomarkers
por: Goyal, Devendra, et al.
Publicado: (2018)

Cerebrospinal fluid biomarkers of Alzheimer's disease in a cohort of adults with Down syndrome
por: Henson, Rachel L., et al.
Publicado: (2020)

Developmental lead exposure and lifespan alterations in epigenetic regulators and their correspondence to biomarkers of Alzheimer's disease
por: Eid, Aseel, et al.
Publicado: (2016)

Standardizing salivary lactoferrin measurements to obtain a robust diagnostic biomarker for Alzheimer's disease
por: Bartolome, Fernando, et al.
Publicado: (2021)

Associations Between the Digital Clock Drawing Test and Brain Volume: Large Community-Based Prospective Cohort (Framingham Heart Study)
por: Yuan, Jing, et al.
Publicado: (2022)

Moderate intensity physical activity associates with CSF biomarkers in a cohort at risk for Alzheimer's disease
por: Law, Lena L., et al.
Publicado: (2018)

Insulin resistance is related to cognitive decline but not change in CSF biomarkers of Alzheimer's disease in non‐demented adults
por: Ennis, Gilda E., et al.
Publicado: (2021)

Disclosure of preclinical Alzheimer's disease biomarker results in research and clinical settings: Why, how, and what we still need to know
por: Erickson, Claire M., et al.
Publicado: (2021)

Function and clinical meaningfulness of treatments for mild Alzheimer's disease
por: Siemers, Eric, et al.
Publicado: (2016)

Temporal association of neuropsychological test performance using unsupervised learning reveals a distinct signature of Alzheimer's disease status
por: Joshi, Prajakta S., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ac18iftge71rm67jdjkfqcar0m